Research Articles

In-depth guides, research summaries, and educational content for the scientific community.

Lyophilized peptide shelf life guide showing storage conditions and stability timelines

How Long Do Lyophilized Peptides Last? Shelf Life, Storage Conditions, and Real-World Data

An evidence-based guide to the shelf life of lyophilized peptides under various storage conditions. Covers stability timelines at room temperature, 4°C, -20°C, and -80°C, the influence of amino acid composition on longevity, how residual moisture and packaging affect degradation rates, practical indicators of expired peptides, and when to re-test stored material before use in experiments.

Mar 9, 2026 · 14 min read
Lyophilized Peptides Shelf Life Peptide Storage
Evaluating peptide blend quality through HPLC mass spectrometry and certificate of analysis review

Evaluating Peptide Blend Quality: Testing, Purity, and Red Flags

A practical guide for researchers evaluating the quality of peptide blend products. Covers what a credible blend certificate of analysis should contain, how to interpret HPLC data for multi-component systems, mass spectrometry requirements for identity confirmation of each component, the critical role of net peptide content in ratio accuracy, chromatographic resolution challenges for blends with similarly sized peptides, red flags that indicate substandard manufacturing, the case for independent third-party verification, and a systematic quality checklist that researchers can apply to any blend product.

Mar 9, 2026 · 16 min read
Peptide Blend Quality HPLC Mass Spectrometry
Peptide blend stability analysis comparing degradation risks in Wolverine GLOW and KLOW formulations

Peptide Blend Stability: Do Combined Peptides Degrade Faster?

A detailed scientific analysis of stability considerations specific to multi-peptide blend formulations. Examines whether co-lyophilized peptides degrade faster than individually stored peptides, covering the mechanisms by which shared microenvironments introduce degradation risks not present in single-peptide systems. Discusses copper-mediated oxidation in GHK-Cu-containing blends, pH compromise effects, cross-reactive degradation products, competitive surface adsorption, reconstituted solution stability timelines, and practical storage protocols tailored to blend complexity. Compares stability profiles across Wolverine, GLOW, and KLOW formulations.

Mar 9, 2026 · 16 min read
Peptide Blend Stability Degradation Oxidation
Peptide blend manufacturing process showing co-lyophilization formulation and quality control steps

How Peptide Blends Are Made: Formulation, Co-Lyophilization, and Quality Risks

A detailed technical guide to how peptide blends are manufactured. Covers the complete production workflow from individual peptide synthesis through purification, quality verification, solution-phase blending, co-lyophilization, and final product testing. Explains the critical formulation challenges of combining multiple peptides including pH compromise, excipient compatibility, freezing rate optimization, and residual moisture control. Discusses quality risks including inaccurate ratios, cross-contamination, degradation during co-processing, and the limitations of blend-level analytical testing compared with individual peptide verification.

Mar 9, 2026 · 16 min read
Peptide Blends Co-Lyophilization Peptide Synthesis
KLOW blend combining BPC-157 TB-500 GHK-Cu and KPV peptides for multi-pathway regeneration research

The KLOW Blend: BPC-157, TB-500, GHK-Cu, and KPV Multi-Pathway Research

A comprehensive scientific analysis of the KLOW blend — a four-peptide co-lyophilized formulation combining GHK-Cu (50 mg), KPV (10 mg), BPC-157 (10 mg), and TB-500 (10 mg) for a total of 80 mg. Covers how KPV extends the GLOW combination by adding dedicated NF-kB-mediated anti-inflammatory modulation, the alpha-MSH-derived tripeptide mechanism of action, PepT1 transporter-mediated intestinal uptake, formulation complexity of four-component systems, stability considerations, quality verification challenges, comparison with simpler blend formulations, and practical guidance for researchers.

Mar 9, 2026 · 17 min read
KLOW Blend BPC-157 TB-500
GLOW blend combining BPC-157 TB-500 and GHK-Cu peptides for regeneration and tissue remodeling research

The GLOW Blend: BPC-157, TB-500, and GHK-Cu for Regeneration Research

A comprehensive scientific analysis of the GLOW blend — a three-peptide co-lyophilized formulation combining BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg). Covers how GHK-Cu extends the Wolverine combination by adding extracellular matrix remodeling and collagen synthesis capabilities, the copper tripeptide mechanism of action, formulation ratios and the significance of the copper ion, stability considerations including metal-catalyzed oxidation risks unique to copper-containing blends, reconstitution protocols, quality verification challenges for three-component systems, and practical guidance for researchers.

Mar 9, 2026 · 17 min read
GLOW Blend BPC-157 TB-500
Wolverine blend combining BPC-157 and TB-500 peptides for tissue repair and regeneration research

The Wolverine Blend: BPC-157 + TB-500 Research Rationale and Practical Guide

A detailed scientific analysis of the Wolverine blend — the combination of BPC-157 and TB-500 (thymosin beta-4 fragment) in a single co-lyophilized formulation. Covers the complementary mechanisms of each peptide, the theoretical rationale for combining them, the preclinical evidence base for each component, formulation details and typical ratios, reconstitution and handling protocols, stability considerations specific to this two-peptide system, quality verification approaches, limitations of the current evidence, and practical guidance for researchers evaluating this combination.

Mar 9, 2026 · 18 min read
Wolverine Blend BPC-157 TB-500
Peptide blends research guide covering Wolverine GLOW and KLOW formulations for scientists

Peptide Blends: What They Are, How They Work, and What Researchers Should Know

A comprehensive guide to peptide blends for researchers. Covers the scientific rationale for combining peptides, how blends are formulated through co-lyophilization, the major named blends including the Wolverine (BPC-157 + TB-500), GLOW (BPC-157 + TB-500 + GHK-Cu), and KLOW (BPC-157 + TB-500 + GHK-Cu + KPV) formulations, stability considerations for multi-peptide systems, quality verification challenges, and the critical distinctions between co-formulated blends and independently sourced peptide stacks.

Mar 9, 2026 · 21 min read
Peptide Blends Wolverine Blend GLOW Blend
SLU-PP-915 ERR pan-agonist exercise mimetic compound for metabolic and cardiovascular research

SLU-PP-915: Orally Active ERR Pan-Agonist and Exercise Mimetic

A comprehensive scientific overview of SLU-PP-915, an orally bioavailable pan-agonist of the estrogen-related receptor (ERR) nuclear receptor family. Covers its chemical design from a boronic acid thiophene scaffold, mechanism of action through ERR-alpha, -beta, and -gamma activation, exercise mimetic properties including enhanced aerobic capacity and Ddit4 induction, cardioprotective effects in pressure-overload heart failure models, metabolic gene regulation, oral pharmacokinetics, synergy with physical exercise, relationship to the SLU-PP-332 predecessor, and the therapeutic potential for obesity, heart failure, sarcopenia, and metabolic disorders.

Mar 9, 2026 · 20 min read
SLU-PP-915 ERR Agonist Exercise Mimetic
NA-931 quadruple receptor agonist targeting IGF-1 GLP-1 GIP and glucagon pathways for metabolic research

NA-931: Oral Quadruple Receptor Agonist — Complete Research Guide

A science-based overview of NA-931, a first-in-class oral quadruple receptor agonist targeting IGF-1, GLP-1, GIP, and glucagon pathways. Covers the molecular rationale derived from cyclic glycine-proline, the four-receptor mechanism of action, Phase 1 and Phase 2 clinical trial data presented at ADA and EASD 2025, reported safety and tolerability profile, comparison with existing incretin therapies, current limitations of the evidence base, and the outlook for Phase 3 development.

Mar 9, 2026 · 19 min read
NA-931 NA-931 GLP-1 Agonist
Research peptides molecular structure and laboratory science overview

What Are Research Peptides? Science, Applications, and Safety

A comprehensive scientific introduction to research peptides. Learn what peptides are, how they differ from proteins and small molecules, how they are synthesized, their major research applications, and the quality and safety considerations that apply to laboratory use.

Mar 4, 2026 · 12 min read
Research Peptides Peptide Science Solid-Phase Synthesis
Independent laboratory performing third-party analytical testing on research peptides

Third-Party Testing for Research Peptides: Purity, Potency, and Safety

A scientific guide to third-party testing for research peptides. Learn why independent verification matters, what analytical tests are performed, how to evaluate testing laboratories, and how third-party results complement manufacturer COAs.

Mar 4, 2026 · 11 min read
Third-Party Testing Peptide Testing Quality Control